Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medco Creates Largest U.S. Specialty Pharmacy Through Accredo Acquisition

This article was originally published in The Pink Sheet Daily

Executive Summary

The companies' combined specialty drug sales were about $4.3 bil. in 2004. The acquisition puts Medco in a position to take a large share of Medicare Part B drug business in addition to its stake in the Part D outpatient drug benefit.
Advertisement

Related Content

Accredo Expands Hemophilia Business With Purchase Of Pediatric Services of America
Accredo Expands Hemophilia Business With Purchase Of Pediatric Services of America
Medco Commits $20 Mil. To Part D Development, Implementation Costs
Medco Commits $20 Mil. To Part D Development, Implementation Costs
Express Scripts Makes Specialty Pharmacy Portfolio A Priority Through Acquisition
Avonex Labeling Change Will Not Affect Sales, Accredo CFO Says
Aetna Members To Exclusively Use Specialty Pharmacy Joint Venture By October
Medco Plans National Medicare Rx Presence: At Risk But Invisible
Medco Bulks Up On Specialty Pharmacy With Accredo Health Agreement
Medco Bulks Up On Specialty Pharmacy With Accredo Health Agreement

Topics

Advertisement
UsernamePublicRestriction

Register

PS061618

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel